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CONGRESSIONAL BUDGET OFFICE Douglas W. Elmendorf, Director 
U.S. Congress 
Washington, DC  20515 
May 26, 2011 
 
 
Honorable Henry A. Waxman 
Ranking Member 
Committee on Energy 
   and Commerce 
U.S. House of Representatives 
Washington, DC 20515 
 
Dear Congressman: 
 
In response to your request, this letter discusses the budgetary effects of 
legislation that would permanently prevent the use of appropriated funds to 
implement the Patient Protection and Affordable Care Act of 2010 
(PPACA) and provisions related to health care in the Health Care and 
Education Reconciliation Act of 2010, Public Laws 111-148 and 111-152, 
respectively.1
 
 
The Congressional Budget Office (CBO) and the staff of the Joint 
Committee on Taxation (JCT) have previously estimated the effects of 
legislation that would temporarily prevent the use of appropriated funds to 
implement PPACA and the Reconciliation Act. Specifically, earlier this 
year, CBO and JCT estimated the budgetary effects of enacting section 
4017 of H.R. 1, the Full-Year Continuing Resolution Act, as passed by the 
House of Representatives on February 19, 2011. That provision would have 
prevented the use of funds appropriated in H.R. 1—that is, any funding for 
fiscal year 2011—to implement PPACA and the Reconciliation Act.2 CBO 
and JCT found that such a temporary prohibition, extending through the 
remainder of fiscal year 2011, would reduce the budget deficit by about 
$1.4 billion in 2011 but would increase deficits by almost $6 billion over 
the 2011-2021 period.3
                                                          
1  The Reconciliation Act (P.L. 111-152) also included provisions affecting education. The  
 H.R. 1 was ultimately supplanted by H. R. 1473, the 
 effects of a prohibition on the use of funds to implement any provisions of PPACA and the  
 Reconciliation Act would affect spending on education, but this letter focuses only on the  
 health care provisions of the act. 
2  Section 4017 of H.R. 1 applied to both the health care and education provisions of the  
 Reconciliation Act; CBO’s estimate for H.R.1 therefore included both of those effects. 
3  Congressional Budget Office, cost estimate for H.R. 1, Full-Year Continuing Appropriations  
 Act of 2011 (March 10, 2011). 
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Department of Defense and Continuing Appropriations Act of 2011, which 
did not include a provision like section 4017 of H.R. 1. 
 
The budgetary effects of a permanent prohibition would be much greater, 
but CBO and JCT cannot estimate the magnitude of those effects—or even 
whether the effects would, on balance, increase or decrease budget deficits. 
According to JCT, a permanent prohibition on the use of appropriated 
funding for implementation would result in a significant loss of revenues. 
However, CBO cannot determine whether changes in spending under a 
permanent prohibition would produce net costs or net savings relative to its 
baseline projection, which assumes full implementation. 
 
PPACA and the Reconciliation Act provided some (mandatory) funding for 
implementing the health care and revenue provisions of those two acts. 
However, CBO and JCT estimate that existing funding is not sufficient to 
implement all of the provisions of the 2010 legislation; some additional 
funding will be needed in future years. In their March 2010 estimate for the 
health care legislation as it was enacted, CBO and JCT estimated that the 
Internal Revenue Service (IRS) and the Department of Health and Human 
Services (HHS) would each require about $5 billion to $10 billion over 
10 years to implement the law.4
 
 Therefore, CBO and JCT expect that a 
permanent ban on the use of appropriations to implement PPACA and the 
health care provisions of the Reconciliation Act would significantly alter 
the effects of many provisions of the legislation, including changes to 
Medicare; the establishment of health insurance exchanges, tax credits, and 
cost-sharing subsidies designed to increase the number of Americans with 
health insurance; changes to Medicaid; and other provisions that affect 
federal revenues. Among other consequences, CBO and JCT expect that 
such a ban would reduce the number of people with health insurance 
coverage compared with what would occur if the health care laws are fully 
implemented. 
This letter discusses many of the potential effects of a permanent ban on the 
use of appropriated funds to implement the health care laws and, where 
possible, provides information on whether those effects would increase or 
decrease direct spending or revenues. Because of the uncertainties 
discussed below, however, CBO and JCT do not have sufficient basis to 
provide a comprehensive estimate of the budgetary effects of legislation 
that would prohibit the use of funding to implement the 2010 health laws, 
yet would not repeal any provisions of that law. 
                                                          
4  Congressional Budget Office, cost estimate for H.R. 4872, Reconciliation Act of 2010 (Final  
 Health Care Legislation) (March 20, 2010).  
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General Issues 
 
A permanent prohibition on the use of appropriated funds for 
implementation would have varying impacts on different provisions of the 
health care laws, and the specific effects of such a prohibition would 
depend on the specific legislative language. The 2010 health care 
legislation includes some provisions that will go into effect without any 
further administrative action on the part of the federal government and 
others that have already been implemented. Many provisions with 
substantial effects on spending and revenues, however, require some 
administrative actions and thus would be significantly affected by a 
prohibition on the use of future appropriated funds for implementation. 
 
The effects of a permanent prohibition would depend to a large extent on 
how the Administration chose to interpret the prohibition on use of funds 
for implementation. For some provisions of law, it is difficult to delineate 
between activities that HHS would be able to undertake and those that 
would be prohibited.5
 
 Other provisions of the health care laws established 
some legal rights on the part of providers, states, or individuals who could 
demand certain benefits or payments. Still other provisions created new 
responsibilities for individuals, businesses, and other entities. A legislative 
prohibition on the use of funding to implement the health care laws would 
not necessarily abrogate those rights or responsibilities. It is very difficult 
for CBO and JCT to determine with any certainty how affected agencies 
would resolve the conflict between tasks required by the health care laws 
and the lack of funding to administer those requirements. 
Finally, some provisions direct other entities—such as states and 
pharmaceutical manufacturers—to implement changes. It is unclear 
whether and how those entities would move forward in response to the laws 
without any guidance or direction from HHS, the IRS, or the Centers for 
Medicare and Medicaid Services (CMS). 
  
                                                          
5  The funding for Medicare benefits and matching payments to states for Medicaid is mandatory,  
 so the funds to make those payments would be available; the question is whether a ban on 
 using appropriated funds would block or inhibit the process of determining and making those 
 payments.  
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A permanent prohibition on the use of discretionary funding to implement 
PPACA and the Reconciliation Act would have some effects that would 
reduce the federal deficit and others that would increase the federal deficit. 
For example, such a prohibition could: 
 
• Prevent CMS from modifying Medicare’s payment rates on an 
annual basis; 
• Preclude CMS from engaging in the rate-setting process and signing 
contracts with the private insurers that offer Medicare Advantage 
and Part D (prescription drug) plans; 
• Preclude the Secretary of HHS from implementing recommendations 
of the Independent Payment Advisory Board (IPAB), aimed at 
limiting Medicare costs; 
• Prevent enforcement of the mandate for U.S. residents to obtain 
health insurance; 
• Prevent the federal government from setting up insurance exchanges 
if states chose not to establish them; 
• Preclude CMS from issuing guidance or offering technical assistance 
to states on expanding their Medicaid programs to newly eligible 
people; 
• Prevent CMS from assessing and collecting its share of higher 
rebates from pharmaceutical manufacturers for drugs dispensed to 
Medicaid beneficiaries; and 
• Bar the IRS from modifying forms, instructions, and publications to 
reflect changes in tax law. 
 
By reducing or preventing enforcement of the mandate to obtain insurance 
coverage, support for states to expand their Medicaid programs, the 
availability of new insurance exchanges, and the use of tax subsidies for 
insurance purchased through those exchanges, a permanent prohibition on 
the use of discretionary funding would reduce the number of people with 
health insurance coverage compared with what would occur if the health 
care laws are fully implemented. 
 
For purposes of this analysis, CBO and JCT assumed that a permanent 
funding prohibition would be enacted late in fiscal year 2011 and would be 
effective as of October 1, 2011 (the beginning of fiscal year 2012). As a 
result, ongoing activities to begin the process of implementing the health 
care legislation would continue through the remainder of this fiscal year; 
those efforts would accomplish some of the steps necessary for full 
implementation, but would fall well short of completing all the actions 
necessary to implement and enforce the 2010 laws. 
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Effects on Medicare  
 
PPACA and the Reconciliation Act modified Medicare’s payment rules for 
nearly all providers and services and made a number of other changes to 
Medicare that would be affected by a prohibition on the use of appropriated 
funds.  
 
Fee-for-Service Payments. Nearly all fee-for-service providers, except 
physicians, are scheduled to receive downward adjustments to their annual 
payment updates, reflecting expected productivity gains. The health care 
laws made no specific changes to annual updates to payment rates for 
physician services, but payments to doctors would nonetheless be affected 
because other changes made by the laws will affect the calculation of the 
conversion factor that is the basis for Medicare’s payments to physicians. 
Therefore, a ban on the use of discretionary funding for implementation 
could prevent CMS from modifying payment rates on an annual basis.  
 
There is no obvious alternative to the updated payment rates, as the relevant 
provisions of the Social Security Act (as amended by PPACA and the 
Reconciliation Act) would not change—and the previous laws governing 
payment rates no longer apply. As a practical matter, that probably means 
that there would be no update to the computer programs (the so-called 
pricers) that contractors use to process and pay fee-for-service claims. 
Thus, unless the Administration found a way to use other authority—such 
as demonstration authority—to modify payment rates or the courts 
intervened following litigation, the effective result would probably be that 
payment rates would remain at current levels. Assuming that a funding 
prohibition would take effect on October 1, 2011, Medicare fee-for-service 
payment systems that operate on a fiscal-year basis (primarily those for 
institutional providers, like hospitals) would not be affected until fiscal year 
2013, as CMS would be able to establish the fiscal year 2012 rates before a 
funding prohibition took effect. Calendar-year payment systems (those for 
physicians and other outpatient providers) would be affected 
immediately—that is, for calendar year 2012.6
 
  
                                                          
6  Most payment systems in Part A of Medicare (including those for hospitals and skilled nursing  
 facilities) operate on a fiscal-year basis—that is, new payment amounts and policies take effect  
 on October 1 of each year. CMS issues the final payment rules for fiscal-year systems around  
 August 1. Payment systems in Medicare Part B (including those for physicians and other  
 outpatient providers) operate on a calendar-year basis; new payment amounts and policies are  
 effective on January 1 of each year. CMS issues the final payment rules for calendar-year  
 providers around November 1. 
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Freezing payment rates for physicians’ services would increase spending 
relative to current law because those rates are scheduled to drop in 2012; in 
contrast, freezing payment rates for other fee-for-service providers would 
reduce spending because those rates are scheduled to rise under current law. 
Thus, if a ban on the use of discretionary funding had the effect of freezing 
payment rates in the fee-for-service sector, Medicare spending would 
increase in 2012 and 2013, and would be reduced—compared with 
projected spending under current law—in 2014 and subsequent years. 
 
Medicare Advantage and Part D. PPACA and the Reconciliation Act 
included changes to both Medicare Advantage (MA) and the Part D drug 
benefit programs, including modifications to the payment rates for MA 
plans and benefit enhancements in Part D. Both MA and Part D operate on 
a calendar-year basis, and each year’s benefit structure and payment 
policies will reflect the changes made by the health care laws. A prohibition 
on the use of funds for administrative activities would not have an effect 
until calendar year 2013, because CBO expects that CMS would sign 
contracts with plans for the 2012 plan-year prior to October 1, 2011.7 
Beginning with plan-year 2013, however, a prohibition on the use of funds 
could preclude CMS from engaging in the rate-setting process and signing 
contracts with the private insurers that offer MA and Part D plans. As 
contracts expired on December 31, 2012, there would probably be nothing 
to replace them and therefore no MA and Part D plans for Medicare 
beneficiaries. If there were no Part D drug benefit, federal spending would 
decline. (Under current law, CBO projects gross payments for Part D 
benefits to total $77 billion in 2013 and $1.1 trillion over the 2012-2021 
period.) With respect to MA plans, CBO anticipates that all beneficiaries 
would instead receive health care services through the fee-for-service 
program, which would also reduce Medicare spending.8
 
 
The Independent Payment Advisory Board. The 2010 laws established 
the IPAB, which is charged with restraining the growth rate of Medicare 
spending per enrollee. If the growth of such spending is projected to exceed 
specified targets, the IPAB will be required to submit proposals to reduce it, 
and the HHS Secretary will be required to implement those proposals 
unless the Congress acts to change them or otherwise alter the IPAB 
process. In its most recent baseline (issued in March 2011), CBO projected 
that Medicare spending will not exceed the specified targets during the 
                                                          
7  CMS engages in the rate-setting and bid review process beginning early in the year before the  
 next plan year—that is, the process would begin in February 2012 for MA and Part D plans  
 wishing to offer benefits in 2013. 
8  All else equal, a fee-for-service Medicare beneficiary costs less than a beneficiary enrolled in  
 an MA plan, because of the methodology used to set MA payment rates. 
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2012-2021 period and, therefore, that the IPAB process will not be 
triggered during that period. 
 
The IPAB has its own mandatory funding under the health laws, so it would 
not be affected directly by a permanent funding ban. Therefore, if in future 
years, per-capita spending for Medicare increased at a rate sufficient to 
trigger IPAB action, the IPAB could engage in the process of developing 
policies to reduce the program’s spending. However, if there were a 
prohibition on the use of appropriated funds, the Secretary probably would 
not be able to implement the IPAB’s recommendations. 
 
Other Effects on Medicare. The health care laws made numerous other 
changes to Medicare, including modifying payment rates and policies for 
specific providers, changing cost-sharing requirements for beneficiaries, 
and setting policies to reduce waste, fraud, and abuse. The laws also 
mandated demonstrations and pilot projects designed to improve the quality 
and efficiency of care. A permanent prohibition on the use of appropriated 
funding could prevent CMS from implementing many of these changes and 
initiatives—reducing spending in some cases and increasing it in others. 
 
Effects on Implementation of Insurance Coverage Provisions 
 
The 2010 health care legislation established a mandate for most U.S. 
residents to obtain health insurance and provided funding and guidance to 
facilitate the creation of state-based insurance exchanges and subsidies for 
certain individuals and families who purchase coverage through exchanges. 
The legislation also imposed certain new requirements on insurers who 
offer insurance through exchanges and established penalties for certain 
employers if any of their workers obtain subsidized coverage through the 
exchanges. Those insurance and subsidy provisions are scheduled to take 
effect on January 1, 2014. 
 
If federal agencies could not use appropriated funds to administer those 
provisions, CBO and JCT expect that qualified health plans and subsidies 
for qualifying individuals would not be readily accessible and the mandate 
for residents to obtain health insurance could not be enforced. Although 
some individuals and families would probably comply with the requirement 
to obtain health insurance who would not have obtained it in the absence of 
the mandate, the number of individuals and families with health insurance 
would be lower than under current law, and significantly fewer would 
receive coverage through the exchanges.9
                                                          
9  CBO estimates that under current law, by 2021 almost 20 million people will receive  
 Therefore, a prohibition on the 
 subsidized health insurance through exchanges.  
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use of appropriated funding would substantially reduce the amount spent by 
the government on subsidies for cost sharing and premiums; under current 
law, that amount is projected to total more than $700 billion over the 2012-
2021 period.10
 
 
PPACA and the Reconciliation Act provided mandatory funding to HHS 
for grants to states that choose to set up health insurance exchanges. If 
states do not establish those exchanges, the federal government is required 
to step in and set them up. Funding for those state grants—estimated by 
CBO to total about $1.9 billion between 2012 and 2015—was provided in 
PPACA. However, federal administrative activities would be required to 
review grant applications and award and renew grants, so a prohibition on 
the use of appropriations for such administrative activities would probably 
have the result of preventing grants to states from being issued. CBO 
expects that a permanent prohibition would slow down the establishment of 
insurance exchanges. 
 
CBO anticipates that some states would choose to establish health 
insurance exchanges even if the federal government provided neither 
regulatory guidance nor financial assistance to states. Other states, 
however, might be reluctant to establish exchanges (and insurers might be 
unwilling to participate) if subsidies to help purchase health insurance were 
not available. If states chose not to establish exchanges, the prohibition on 
the use of discretionary funds would probably prevent the federal 
government from setting them up itself.11
 
 
Effects on Medicaid and the Children’s Health Insurance Program 
(CHIP)  
 
Matching funds that the federal government provides to states under 
Medicaid and CHIP are mandatory and would be unaffected by a ban on 
using discretionary funds for implementation. However, states administer 
Medicaid and CHIP in accordance with federal law and guidance. In 
addition, the federal government must review and approve most major 
changes to state Medicaid and CHIP plans. It is difficult to predict how 
                                                          
10  This figure includes all premium and cost sharing subsidies. Subsidies for health insurance  
 premiums are structured as refundable tax credits; the portions of such credits that exceed  
 taxpayers’ liabilities are classified as outlays, while the portions that reduce tax payments are  
 reflected in the budget as reductions in revenues 
11  See Congressional Budget Office, cost estimate for H.R. 1213, a bill to repeal funding  
 provided to states in the Patient Protection and Affordable Care Act to establish American  
 Health Benefit exchanges (April 27, 2011). CBO estimated that the bill, if enacted, would  
 reduce deficits by about $14 billion over the 2012-2021 period. 
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states would respond to the lack of guidance from the federal government 
that would probably occur if there were a prohibition on federal agencies’ 
use of funds to implement changes to Medicaid and CHIP. Although such a 
prohibition would not affect the underlying law requiring states to 
undertake particular changes to their Medicaid and CHIP programs, they 
might be reluctant to make those changes without further federal guidance 
or approval.  
 
Under current law, CBO estimates that about 17 million additional 
individuals will be added to the Medicaid and CHIP rolls by 2021, as the 
programs become the primary source of health insurance for nearly all legal 
residents with income below 138 percent of the poverty level. Because 
states administer the enrollment process, CBO anticipates that these newly 
eligible Medicaid and CHIP enrollees could join the programs even if 
discretionary appropriations were not available at the federal level. 
 
States might find that process to be more difficult, however, if CMS were 
unable to provide guidance and support. For example, under current law 
CBO expects that CMS will issue guidance to states about implementing 
the eligibility expansions mandated by the health care laws. If prohibited 
from using appropriated funds to implement the laws, CMS would probably 
not be able to issue such guidance or offer technical advice to the states on 
expanding their Medicaid programs. It is therefore unclear what actions 
states would take to expand coverage as required by law, and different 
states might interpret the law or implement the changes differently. In 
addition, it is uncertain whether states’ ability to determine eligibility based 
on people’s income would be affected by the restrictions on the IRS’s use 
of discretionary funds to implement the health care laws. 
 
Apart from the health insurance expansion, the health care laws made other 
changes to Medicaid and CHIP. For example, the laws increased the rebate 
that pharmaceutical manufacturers pay on drugs dispensed to Medicaid 
beneficiaries. If CMS cannot use discretionary funding to support the 
activities needed to administer the revised rebate agreements, it probably 
would not be able to assess and collect its share of the higher rebates. The 
federal government would therefore not realize savings from increased 
rebates or from other policies that would reduce drug spending in Medicaid. 
CBO estimates that, under current law, savings from all Medicaid drug 
policies under PPACA will total about $48 billion over the 2012-2021 
period. 
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As with Medicare, PPACA and the Reconciliation Act included provisions 
to reduce waste, fraud, and abuse in Medicaid and CHIP, as well as to 
improve the quality and efficiency of the care provided to the programs’ 
enrollees. Without the ability to use appropriated funds, CMS could not 
begin or continue these activities. Similarly, the inability to provide 
technical guidance regarding other Medicaid provisions, like the required 
two-year increase in Medicaid’s reimbursement rates for providers, could 
impede states’ ability to implement those changes. 
 
Given these uncertainties, it is difficult to estimate whether a permanent 
funding ban would increase or decrease Medicaid costs. On the one hand, if 
the Medicaid and CHIP expansions did not occur at all, or if states enrolled 
some but not all of the individuals that CBO estimated would obtain 
Medicaid and CHIP coverage as a result of PPACA and the Reconciliation 
Act, federal spending would be reduced. On the other hand, if the 
expansions occurred anyway, CMS’s inability to implement other Medicaid 
provisions, such as the change in drug rebates, would increase federal 
spending. 
 
Effects on Revenues 
 
JCT expects that a permanent prohibition on the use of discretionary 
funding to implement the revenue provisions of PPACA and the 
Reconciliation Act would significantly reduce receipts from the revenue 
provisions that are not related to insurance coverage. A variety of factors 
could affect the extent of this reduction. The prohibition would not amend 
the Internal Revenue Code or otherwise change the laws affecting taxation; 
it would only inhibit the ability of the IRS to administer the law. For 
example, the prohibition would prevent the IRS from developing and 
publishing new regulations, new tax forms or revisions to tax forms, and 
taxpayer instructions. The prohibition would also prevent the IRS from 
contacting taxpayers or initiating other enforcement activities to collect 
underpayments or liabilities generated by the health care laws. 
Nevertheless, PPACA and the Reconciliation Act created rights and 
responsibilities for taxpayers that are in force whether or not the IRS is able 
to take action to administer the law. 
 
The effect of prohibiting the use of appropriated funds for such purposes 
would depend on the reaction of the public and the IRS to this lack of 
administrative action by the agency. Taxpayers’ willingness to adhere to 
PPACA and Reconciliation Act provisions would depend in part on factors 
such as whether the change in law would be clearly reflected on the form to 
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be submitted to the IRS, whether it would be reflected in regulations and 
tax filing instructions, and, over time, whether the IRS would appear to be 
enforcing compliance with the provisions. 
 
Provisions that are Effective in 2011. In the case of most revenue 
provisions that are effective before the end of fiscal year 2011, tax forms 
and instructions already reflect the provisions, and most taxpayers would 
probably comply with them in the short term. To the extent that those forms 
and instructions could not be changed for subsequent taxable years, some 
degree of compliance might continue, but would probably diminish over 
time. Taxpayers would be more likely to ignore provisions that increased 
their liability than those that reduced their liability. 
 
Provisions effective in 2011 that increase liability include an increase in the 
tax on nonqualified distributions from a health savings account from 
10 percent to 20 percent, an excise tax on indoor tanning services, penalties 
for underpayment of taxes resulting from violation of the economic 
substance doctrine, and a fee for manufacture and importation of certain 
pharmaceutical products (discussed further below). Those provisions are 
currently projected to produce roughly $40 billion in revenues over the 
2012-2021 period. JCT and CBO expect that, over time, there would be a 
significant reduction in revenues collected from these provisions.  
 
The main provision in effect in 2011 that reduces tax liability is a tax credit 
for the purchase of employees’ health insurance by certain small 
businesses. Taxpayers who might be eligible to claim the small business tax 
credit will probably claim it on their return, and would continue to claim it 
in future years if no changes were made to returns or instructions. Over 
time, some taxpayers might take a more aggressive position, claiming 
eligibility for the credit even if they did not meet all of the eligibility 
requirements if they believe that the IRS would be unable to enforce any 
limitations on the provision.  
 
Provisions that will be Implemented After 2011. For provisions that are 
only effective for years after 2011, it is likely that the forms and 
instructions would not reflect the changes enacted in the health care laws, 
and guidance on how to comply with those changes in law would not be 
published. The permanent prohibition might present a conundrum for the 
IRS as to what it could include in its forms and instructions if it could not 
accurately explain present law. For example, in the case of the change in 
the threshold as a percentage of adjusted gross income that a taxpayer’s 
medical expenses must exceed before the expenses are deductible, the IRS 
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might not be able to provide any explanation of the threshold in 
publications for tax years after 2012 because the threshold will have 
increased from 7.5 percent of AGI to 10 percent. Specifically, in 2013 and 
beyond, the IRS would not have the authority to administer that provision 
as it was in effect prior to 2013 (by reflecting the calculation on Schedule A 
of Form 1040 and in the instructions for Schedule A) as that will no longer 
be present law. However, the funding prohibition would prevent resources 
from being spent on changing forms, instructions, and publications to 
reflect changes made by PPACA and the Reconciliation Act. Therefore, the 
IRS might believe it could do no more than explain to taxpayers that there 
are limitations on the amount deductible, perhaps instructing taxpayers to 
consult with a tax professional about the limitations on the deduction. 
 
Two provisions of PPACA and the Reconciliation Act that raise significant 
revenues do not become effective until 2013: an additional Hospital 
Insurance (HI) tax of 0.9 percent on earned income of single filers who earn 
more than $200,000 and on joint filers who earn more than $250,000; and a 
new “Unearned Medical Contribution” tax of 3.8 percent on investment 
income of single filers with adjusted gross incomes above $200,000 and 
joint filers with adjusted gross incomes above $250,000. A third significant 
source of new revenues from PPACA is a 40 percent excise tax on health 
insurance coverage in excess of certain thresholds, which will be effective 
beginning in 2018. Several other provisions in the health care laws that are 
expected to raise revenues, including an excise tax on medical devices, a 
limitation on the deductibility of certain compensation to insurance 
executives, and the elimination of the deductibility of subsidies for 
Medicare Part D will also take effect in 2013. Because the IRS would not 
be able to prepare forms and instructions to facilitate collection of those 
taxes, and would not be able to take enforcement actions in the event that 
taxpayers fail to pay these taxes, most of the revenues anticipated from 
those taxes would probably not be collected. (JCT and CBO estimate that, 
under current law, those provisions of the health care laws will bring in 
several hundred billion dollars over the 2012-2021 period.) 
 
Some provisions of the laws present special problems because the IRS has 
to take a direct role in implementing them. For example, collecting the 
pharmaceutical and insurance industry fees imposed by PPACA and the 
Reconciliation Act will require the IRS to make a determination of each 
taxpayer’s liability each year. The pharmaceutical industry fee takes effect 
in 2011, and the IRS expects to complete its determination and collection of 
the fee this year prior to the assumed effective date of the prohibition. The 
insurance industry fee, however, is not effective until 2013. It is unlikely 
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that the insurance or pharmaceutical industry fees would be collected in 
years after the effective date of legislation that prohibits spending funds for 
implementation because the IRS would not be permitted to administer the 
fees and make the necessary taxpayer determinations. (JCT and CBO 
estimate that, under current law, those fees will generate receipts totaling 
more than $100 billion from 2012 through 2021.) 
 
The tax provision in PPACA and the Reconciliation Act that provides the 
largest benefit to taxpayers is the refundable tax credit for insurance 
purchased through health insurance exchanges. That provision does not 
become effective until 2014. (CBO and JCT estimate that the credit will 
result in a reduction in revenues and additional spending totaling more than 
$600 billion over the 2014-2021 period.)12
 
 Prohibiting the use of 
discretionary funding for implementation of the health care laws would 
result in many states failing to establish health insurance exchanges and 
would probably prevent the federal government from setting them up itself. 
Nevertheless, some states would probably set up exchanges, and persons 
who chose to purchase insurance through those exchanges would be 
eligible to claim the tax credits. Barring the use of funding to administer the 
tax credits would prevent both screening of individuals for eligibility and 
advance payment of the credits. It would also prevent HHS and the IRS 
from publishing guidance about claiming the credit and providing 
appropriate tax filing instructions. Thus, there would probably be a 
significant reduction in use of the tax credit. (However, because some 
people would still be eligible for the credit, there would probably be some 
loss of revenue, possibly through claims appended to tax returns.) In 
addition, the existence of a large refundable credit that the IRS is prohibited 
from overseeing could create tax compliance problems. On net, JCT and 
CBO estimate that a large share of the federal government’s costs 
associated with the exchange credit would be eliminated by a prohibition 
on the use of appropriations to implement the health care laws. 
Role of the Private Sector. Finally, an additional source of uncertainty in 
estimating the effects of prohibiting federally appropriated funds from 
being spent to implement PPACA and the Reconciliation Act is the role of 
the private sector in the tax filing process. Many taxpayers, both individuals 
and business entities, rely on professional assistance or computer software 
to complete their tax forms and calculate their tax liability. It is unclear how 
                                                          
12  In addition to tax credits for premium assistance, certain individuals with lower income will  
 also be entitled to subsidies to reduce the amount they will be required to pay for cost sharing  
 for medical services. Those subsidies are classified as outlays in the budget and are not  
 included in this figure. 
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professional return preparers and software manufacturers might alter the 
advice they provide, knowing that the IRS was prohibited from 
administering certain provisions of the tax code or other laws. Such 
preparers and manufacturers have a duty to provide advice consistent with 
the law, and thus might feel compelled to accurately reflect the tax liability 
on the returns they prepare for their customers (and software they develop) 
despite the collection constraints placed on the IRS. Such advice would be 
consistent with their professional responsibility, and it is reasonable to 
expect that many would advise clients to file in accordance with the tax law 
changes enacted under PPACA and the Reconciliation Act, to the extent 
that they understood those changes to be in effect despite a lack of funding 
for implementation.13
 
 However, many others, either because they 
interpreted the statutory denial of implementation funding as a de facto 
rescission or moratorium, or because they believed it was in the best 
interest of their clients, regardless of their professional duties, might 
alert their customers to the fact that the IRS was prohibited from using 
funds to take action to enforce the law so the customers might be able to 
safely ignore the law. 
I hope this information is helpful. The staff contacts for this analysis are 
Tom Bradley and Jean Hearne for CBO and Bernard Schmitt for JCT. 
 
      Sincerely, 
 
 
 
      Douglas W. Elmendorf 
      Director 
 
cc:  Honorable Fred Upton 
 Chairman 
 
 Thomas A. Barthold 
 Chief of Staff 
 Joint Committee on Taxation 
 
 
Identical letters sent to the Honorable George Miller, the Honorable 
Chris Van Hollen, and the Honorable Sander M. Levin 
                                                          
13 31 C.F.R. 10. 
